THE HAGUE, Netherlands, June 24, 2019 /PRNewswire/ — At Metabolomics 2019 (metabolomics2019.org), Bruker highlights innovative mass spectrometry (MS) and Nuclear Magnetic Resonance (NMR) systems and novel high-value solutions for molecular phenomics and clinical metabolomics research. The proven Bruker IVDr NMR solution, which is based on a fully automated and standardized 600 MHz NMR platform, is... Read more
– Introduction of new MALDI Biotyper sirius™ system with additional negative-ion mode to support MALDI research and RUO validation studies, e.g. for colistin-resistance testing – US introduction of Micronaut™ products for true minimum inhibitory concentration (MIC) antibiotic susceptibility testing (AST) in veterinary medicine – US introduction of RUO versions of MALDI Biotyper-based rapid Selective-Testing of... Read more
BILLERICA, Mass., June 14, 2019 PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) will host an Investor Day on June 20th, 2019, starting at 8:00 AM Eastern Time, at the Nasdaq MarketSite, 4 Times Square in New York City. The Bruker Investor Day will feature business, management process, operational excellence and strategy updates. Moreover, Bruker’s executive leadership... Read more
BOSTON, June 3, 2019 — 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced several advancements to their ZipChip® product line, which build upon its industry-leading biotherapeutic analysis capabilities in multiple critical application areas. These product and application expansions will be showcased at the 67th Annual ASMS Conference being held in... Read more
timsTOF Pro™ System Further Enhanced with MBR-ddaPASEF and diaPASEF for 4D Proteomics timsTOF Pro Ultra-high Sensitivity 4D Proteomics and 4D Lipidomics Advance Single-Cell Biology New Consumables and Software Partners and Products for 4D Proteomics Announced at ASMS 2019 ATLANTA, May 31, 2019 /PRNewswire/ — At the 67th American Society for Mass Spectrometry Conference (ASMS) being... Read more
BILLERICA, Mass., May 28, 2019 /PRNewswire/ — Bruker Corporation (Nasdaq: BRKR) announced today that it will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York on Thursday, June 6, 2019 at 4:00 pm EDT. Presenting for the company will be Frank Laukien, President and Chief Executive Officer, and Juergen Srega,... Read more
High-Precision, Flexible Development of Lubrication Materials May 20, 2019 – At the 74th STLE Annual Meeting and Exhibition, Bruker today announced the release of the High-Frequency Reciprocating Rig (HFRR) Module for the UMT TriboLab™ Mechanical Tester. The new HFRR Module performs a wide range of materials qualification tests and enables effective screening of lubricants and materials at the benchtop scale... Read more
World’s highest field preclinical MRI will be used for oncology and neuroscience research MONTREAL, May 13, 2019 /PRNewswire/ — At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the world’s first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging... Read more
Nijmegen, Netherlands, April 16, 2019 – At the opening event of the Netherlands X-omics Initiative, Bruker and the Translation Metabolic Laboratory (TML) at Radboud University Medical Center (UMC) today jointly announce the establishment of a Center of Excellence (CoE) for Translational Omics. Under the leadership of Professor Alain van Gool, the joint CoE will focus on... Read more
– Reference library expansion for broader species identification by MALDI Biotyper (MBT) – Increased speed for high-throughput projects by multi-threading MBT HT software (RUO) – Increased microbial ID from positive blood cultures with improved Sepsityper™ kit – Easier subtyping for hospital hygiene and infection control with improved IR Biotyper AMSTERDAM, April 15, 2019 /PRNewswire/ — At... Read more